X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

SCYX

Closed

Scynexis Inc

0.71
+0.04 (+5.93%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.6748
Day's Range: 0.672 - 0.73
Send
When Written:
 
3.3
Scynexis Inc. is a biotechnology company that focuses on developing and commercializing innovative therapies to address unmet needs in the treatment of infectious diseases. The company's lead product candidate is ibrexafungerp (formerly SCY-078), an oral and intravenous antifungal agent that is being developed for the treatment of multiple types of fungal infections, including candidiasis, aspergillosis, and rare molds. Scynexis also has a preclinical pipeline of potential antiviral and antibacterial therapies. The company was founded in 1999 and is headquartered in Jersey City, New Jersey.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X